Colin Pritchard
Colin Pritchard, MD, PhD
Colin Pritchard is Professor of Laboratory Medicine and Pathology at the University of Washington Seattle, USA, and Program Director for Cancer Precision Diagnostics at the Brotman Baty Institute for Precision Medicine. He also serves as Co-Director of the Genetics and Solid Tumors Laboratory, which supports the Fred Hutchinson Cancer Center. His clinical work centers on next-generation sequencing gene panels for cancer risk assessment and precision treatment. Pritchard led the development of the ColoSeq™ Lynch and Polyposis Syndrome Panel and the UW-OncoPlex™ Cancer Gene Panel, both of which are used in clinical care for people with cancer and their families.
View content featuring Pritchard:
This content has been developed independently by Medthority who previously received educational funding from Pfizer in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.
of interest
are looking at
saved
next event